2024 Industry Article
Top Use Cases for Artificial Intelligence, Machine Learning, and Blockchain within Drug Development
Pharma Focus Asia – Issue 55, Pages 58-59
AIMachine LearningBlockchainDrug Development
Lifesciences Intelligence
Research and thought leadership.
BioPharMatrix’s published work centers on artificial intelligence, machine learning, blockchain, decentralized drug development, clinical trials, and high-fidelity databases.
2023 Industry Article
Powering Decentralized Drug Development
Enabling downstream disruptive technologies to generate high-fidelity output. Pharma Focus Asia – Issue 53, Pages 26-28.
DecentralizationDrug DevelopmentDisruptive Technology
2023 Industry Article
Blockchain is Mandatory in Constructing a High-Fidelity Database
Preparing downstream disruptive technologies such as artificial intelligence training.
BlockchainAI TrainingDatabase
2021 Conference Handbook
Blockchain and Drug Supply Chain
H1 Virtual Events – Reviews and Summary Handbook, Blockchain, Pages 33-35.
BlockchainSupply Chain
2021 Industry Interview
Emerging Disruptive Technologies in the Pharmaceutical Industry
An interview with Frank Leu, Novapeutics, published by Pharma Features.
Disruptive TechnologyPharma Innovation
2020 Industry Article
Blockchain Enables Machine Learning and AI to Drive a Hyper-Efficient Trial
Clinical Trials, Arena International Events Group, June 16, 2020.
BlockchainMachine LearningClinical Trials
2020 Conference Proceedings
Market Analysis Report on Stem Cells
Journal of Cell Science & Therapy, Volume 12, Issue 2.
Stem CellsRegenerative Medicine
2020 Oncology Handbook
Blockchain Immutable Database Architecture Enables Machine Learning and Artificial Intelligence
A hyper-efficient clinical trial architecture through immutable data foundations.
BlockchainAIOncology